Simple
• Just a blood sample (8-10 ml) from the pregnant woman
Safe
• PrenatalSAFE® is a NON-INVASIVE screening test: safe for the mother and the fetus
• Reduces the risk of abortion-related to traditional invasive prenatal diagnosis techniques, such as amniocentesis and Chorionic villus sampling (CVS).
Reliable
• Concordance of the test for trisomy 13, trisomy 18 and trisomy 21 is 99.9% for singleton pregnancies (Pertile et al., 2021)
Fast
• PrenatalSAFE® results can be available from 3 working days.
| Test | TAT* |
| PrenatalSAFE® 3 | 3 days |
| PrenatalSAFE® 5 | 3 days |
| PrenatalSAFE® Plus | 7 days |
| PrenatalSAFE® Karyo | 7 days |
| PrenatalSAFE® Karyo Plus | 7 days |
| PrenatalSAFE® COMPLETE | 5 (10) days ** |
| PrenatalSAFE® COMPLETE Plus | 7 (10) days ** |
* Turnaround Time (TAT) is the time taken from receipt of the sample in the processing laboratory
to final authorisation of the results in our Laboratory Information System
** The report of the PrenatalSAFE® COMPLETE test consists of two different reports: the first refers to the non-invasive analysis of the fetal karyotype that will be provided in 5 or 7 working days, and the second relating to genetic diseases inherited and / or de novo which will be available after 10 working days. The above mentioned reporting times, however, are not binding and could be prolonged in case of repetitions of the test, not optimal results, diagnostic investigations or interpretative doubts.